Does activated protein C resistance increase the risk of systemic embolism in non rheumatic atrial fibrillation?

被引:3
作者
Eikelboom, J
Thom, J
VanBockxmeer, F
Baker, R
机构
[1] Dept. of Haematology/Biochemistry, Royal Perth Hospital, Perth, WA
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE | 1996年 / 26卷 / 02期
关键词
D O I
10.1111/j.1445-5994.1996.tb00899.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:243 / 244
页数:2
相关论文
共 8 条
[1]   DIAGNOSIS OF ACTIVATED PROTEIN-C RESISTANCE (FACTOR-V LEIDEN) [J].
BAKER, R ;
THOM, J ;
VANBOCKXMEER, F .
LANCET, 1994, 344 (8930) :1162-1162
[3]  
Meyer B J, 1994, Curr Opin Hematol, V1, P336
[4]   MUTATION IN THE GENE CODING FOR COAGULATION-FACTOR-V AND THE RISK OF MYOCARDIAL-INFARCTION, STROKE, AND VENOUS THROMBOSIS IN APPARENTLY HEALTHY-MEN [J].
RIDKER, PM ;
HENNEKENS, CH ;
LINDPAINTER, K ;
STAMPFER, MJ ;
EISENBERG, PR ;
MILETICH, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14) :912-917
[5]   SURVIVAL AND RECURRENCE FOLLOWING STROKE - THE FRAMINGHAM-STUDY [J].
SACCO, RL ;
WOLF, PA ;
KANNEL, WB ;
MCNAMARA, PM .
STROKE, 1982, 13 (03) :290-295
[6]  
Stroke Prevention in Atrial Fibrillation Investigators, 1994, LANCET, V343, P687
[7]   PREMATURE ISCHEMIC-HEART-DISEASE AND THE GENE FOR COAGULATION-FACTOR-V [J].
VANBOCKXMEER, FM ;
BAKER, RI ;
TAYLOR, RR .
NATURE MEDICINE, 1995, 1 (03) :185-185
[8]   ASPIRIN OR WARFARIN FOR NONRHEUMATIC ATRIAL-FIBRILLATION [J].
WHITE, HD .
LANCET, 1994, 343 (8899) :683-684